Current status of proteomics research in diabetic retinopathy
10.3980/j.issn.1672-5123.2025.3.16
- VernacularTitle:糖尿病视网膜病变的蛋白质组学研究现状
- Author:
Shun ZHOU
1
;
Yan WANG
1
;
Jing LENG
1
;
Yong ZHAO
1
Author Information
1. The Fourth Clinical Medical College, Xinjiang Medical University, Urumqi 830000, Xinjiang Uygur Autonomous Region, China
- Publication Type:Journal Article
- Keywords:
diabetic retinopathy;
proteomics;
differentially expressed protein
- From:
International Eye Science
2025;25(3):428-433
- CountryChina
- Language:Chinese
-
Abstract:
Diabetic retinopathy(DR)has emerged as the leading cause of vision loss among working-age people in many countries under the increasing prevalence of diabetes and the longevity of the population. The pathogenesis of DR is complicated and has not been fully elucidated at present, while the treatment methods of DR have not been greatly improved, mainly retinal laser photocoagulation, anti-vascular endothelial growth factor(VEGF)treatment and vitrectomy surgery. The current treatment methods not only have shortcomings, but also bring serious economic burden to patients. Therefore, new methods are needed to explore the pathogenesis of DR, discover new treatments or improve current treatments, and improve the satisfaction of DR patients. In recent years, the identification and quantification of proteins expressed in blood, retina, vitreous humor, aqueous humor, and tears of all observable DR patients and DR rats and differentially expressed proteins after drug intervention have provided new ideas for further exploring the pathogenesis, diagnosis and treatment of DR with the rise of proteomics, which put forward new insights into early detection and treatment.The proteomics of DR in recent years are reviewed, in order to provide new ideas for the diagnosis and treatment of DR.
